Clinical Research Trials Archive – Closed Trials

This is our archive of closed clinical trials, which means that they are no longer accepting new participants or have been concluded. Once a research facility has chosen to close the study, it is sorted into the GPS archive by indication. If you are interested in enrolling in a clinical trial, then please browse our list of active clinical studies.

Zip code

Condition


Search Radius:25 Miles
  • 5
  • 10
  • 15
  • 20
  • 25
  • 30
  • 40
  • 50
  • 100
  • 500
  • All

We've found
896
archived clinical trials in
Gastroesophageal Reflux Disease

Rabeprazole Extended-Release 50 mg Versus Esomeprazole 40 mg for Healing and Symptomatic Relief of Mild to Moderate Erosive Gastroesophageal Reflux Disease (GERD)
A Randomized Double-Blind Parallel Study of Rabeprazole Extended-Release 50 mg Versus Esomeprazole 40 mg for Healing and Symptomatic Relief of Mild to Moderate Erosive Gastroesophageal Reflux Disease (GERD)
Status: Enrolling
Updated:  1/11/2016
mi
from
Franklin, TN
Rabeprazole Extended-Release 50 mg Versus Esomeprazole 40 mg for Healing and Symptomatic Relief of Mild to Moderate Erosive Gastroesophageal Reflux Disease (GERD)
A Randomized Double-Blind Parallel Study of Rabeprazole Extended-Release 50 mg Versus Esomeprazole 40 mg for Healing and Symptomatic Relief of Mild to Moderate Erosive Gastroesophageal Reflux Disease (GERD)
Status: Enrolling
Updated: 1/11/2016
Clinical Research Facility
mi
from
Franklin, TN
Click here to add this to my saved trials
Rabeprazole Extended-Release 50 mg Versus Esomeprazole 40 mg for Healing and Symptomatic Relief of Mild to Moderate Erosive Gastroesophageal Reflux Disease (GERD)
A Randomized Double-Blind Parallel Study of Rabeprazole Extended-Release 50 mg Versus Esomeprazole 40 mg for Healing and Symptomatic Relief of Mild to Moderate Erosive Gastroesophageal Reflux Disease (GERD)
Status: Enrolling
Updated:  1/11/2016
mi
from
Germantown, TN
Rabeprazole Extended-Release 50 mg Versus Esomeprazole 40 mg for Healing and Symptomatic Relief of Mild to Moderate Erosive Gastroesophageal Reflux Disease (GERD)
A Randomized Double-Blind Parallel Study of Rabeprazole Extended-Release 50 mg Versus Esomeprazole 40 mg for Healing and Symptomatic Relief of Mild to Moderate Erosive Gastroesophageal Reflux Disease (GERD)
Status: Enrolling
Updated: 1/11/2016
Clinical Research Facility
mi
from
Germantown, TN
Click here to add this to my saved trials
Rabeprazole Extended-Release 50 mg Versus Esomeprazole 40 mg for Healing and Symptomatic Relief of Mild to Moderate Erosive Gastroesophageal Reflux Disease (GERD)
A Randomized Double-Blind Parallel Study of Rabeprazole Extended-Release 50 mg Versus Esomeprazole 40 mg for Healing and Symptomatic Relief of Mild to Moderate Erosive Gastroesophageal Reflux Disease (GERD)
Status: Enrolling
Updated:  1/11/2016
mi
from
Jackson, TN
Rabeprazole Extended-Release 50 mg Versus Esomeprazole 40 mg for Healing and Symptomatic Relief of Mild to Moderate Erosive Gastroesophageal Reflux Disease (GERD)
A Randomized Double-Blind Parallel Study of Rabeprazole Extended-Release 50 mg Versus Esomeprazole 40 mg for Healing and Symptomatic Relief of Mild to Moderate Erosive Gastroesophageal Reflux Disease (GERD)
Status: Enrolling
Updated: 1/11/2016
Clinical Research Facility
mi
from
Jackson, TN
Click here to add this to my saved trials
Rabeprazole Extended-Release 50 mg Versus Esomeprazole 40 mg for Healing and Symptomatic Relief of Mild to Moderate Erosive Gastroesophageal Reflux Disease (GERD)
A Randomized Double-Blind Parallel Study of Rabeprazole Extended-Release 50 mg Versus Esomeprazole 40 mg for Healing and Symptomatic Relief of Mild to Moderate Erosive Gastroesophageal Reflux Disease (GERD)
Status: Enrolling
Updated:  1/11/2016
mi
from
Johnson City, TN
Rabeprazole Extended-Release 50 mg Versus Esomeprazole 40 mg for Healing and Symptomatic Relief of Mild to Moderate Erosive Gastroesophageal Reflux Disease (GERD)
A Randomized Double-Blind Parallel Study of Rabeprazole Extended-Release 50 mg Versus Esomeprazole 40 mg for Healing and Symptomatic Relief of Mild to Moderate Erosive Gastroesophageal Reflux Disease (GERD)
Status: Enrolling
Updated: 1/11/2016
Clinical Research Facility
mi
from
Johnson City, TN
Click here to add this to my saved trials
Rabeprazole Extended-Release 50 mg Versus Esomeprazole 40 mg for Healing and Symptomatic Relief of Mild to Moderate Erosive Gastroesophageal Reflux Disease (GERD)
A Randomized Double-Blind Parallel Study of Rabeprazole Extended-Release 50 mg Versus Esomeprazole 40 mg for Healing and Symptomatic Relief of Mild to Moderate Erosive Gastroesophageal Reflux Disease (GERD)
Status: Enrolling
Updated:  1/11/2016
mi
from
Kingsport, TN
Rabeprazole Extended-Release 50 mg Versus Esomeprazole 40 mg for Healing and Symptomatic Relief of Mild to Moderate Erosive Gastroesophageal Reflux Disease (GERD)
A Randomized Double-Blind Parallel Study of Rabeprazole Extended-Release 50 mg Versus Esomeprazole 40 mg for Healing and Symptomatic Relief of Mild to Moderate Erosive Gastroesophageal Reflux Disease (GERD)
Status: Enrolling
Updated: 1/11/2016
Clinical Research Facility
mi
from
Kingsport, TN
Click here to add this to my saved trials
Rabeprazole Extended-Release 50 mg Versus Esomeprazole 40 mg for Healing and Symptomatic Relief of Mild to Moderate Erosive Gastroesophageal Reflux Disease (GERD)
A Randomized Double-Blind Parallel Study of Rabeprazole Extended-Release 50 mg Versus Esomeprazole 40 mg for Healing and Symptomatic Relief of Mild to Moderate Erosive Gastroesophageal Reflux Disease (GERD)
Status: Enrolling
Updated:  1/11/2016
mi
from
Nashville, TN
Rabeprazole Extended-Release 50 mg Versus Esomeprazole 40 mg for Healing and Symptomatic Relief of Mild to Moderate Erosive Gastroesophageal Reflux Disease (GERD)
A Randomized Double-Blind Parallel Study of Rabeprazole Extended-Release 50 mg Versus Esomeprazole 40 mg for Healing and Symptomatic Relief of Mild to Moderate Erosive Gastroesophageal Reflux Disease (GERD)
Status: Enrolling
Updated: 1/11/2016
Clinical Research Facility
mi
from
Nashville, TN
Click here to add this to my saved trials
Rabeprazole Extended-Release 50 mg Versus Esomeprazole 40 mg for Healing and Symptomatic Relief of Mild to Moderate Erosive Gastroesophageal Reflux Disease (GERD)
A Randomized Double-Blind Parallel Study of Rabeprazole Extended-Release 50 mg Versus Esomeprazole 40 mg for Healing and Symptomatic Relief of Mild to Moderate Erosive Gastroesophageal Reflux Disease (GERD)
Status: Enrolling
Updated:  1/11/2016
mi
from
Beaumont, TX
Rabeprazole Extended-Release 50 mg Versus Esomeprazole 40 mg for Healing and Symptomatic Relief of Mild to Moderate Erosive Gastroesophageal Reflux Disease (GERD)
A Randomized Double-Blind Parallel Study of Rabeprazole Extended-Release 50 mg Versus Esomeprazole 40 mg for Healing and Symptomatic Relief of Mild to Moderate Erosive Gastroesophageal Reflux Disease (GERD)
Status: Enrolling
Updated: 1/11/2016
Clinical Research Facility
mi
from
Beaumont, TX
Click here to add this to my saved trials
Rabeprazole Extended-Release 50 mg Versus Esomeprazole 40 mg for Healing and Symptomatic Relief of Mild to Moderate Erosive Gastroesophageal Reflux Disease (GERD)
A Randomized Double-Blind Parallel Study of Rabeprazole Extended-Release 50 mg Versus Esomeprazole 40 mg for Healing and Symptomatic Relief of Mild to Moderate Erosive Gastroesophageal Reflux Disease (GERD)
Status: Enrolling
Updated:  1/11/2016
mi
from
Bryan, TX
Rabeprazole Extended-Release 50 mg Versus Esomeprazole 40 mg for Healing and Symptomatic Relief of Mild to Moderate Erosive Gastroesophageal Reflux Disease (GERD)
A Randomized Double-Blind Parallel Study of Rabeprazole Extended-Release 50 mg Versus Esomeprazole 40 mg for Healing and Symptomatic Relief of Mild to Moderate Erosive Gastroesophageal Reflux Disease (GERD)
Status: Enrolling
Updated: 1/11/2016
Clinical Research Facility
mi
from
Bryan, TX
Click here to add this to my saved trials
Rabeprazole Extended-Release 50 mg Versus Esomeprazole 40 mg for Healing and Symptomatic Relief of Mild to Moderate Erosive Gastroesophageal Reflux Disease (GERD)
A Randomized Double-Blind Parallel Study of Rabeprazole Extended-Release 50 mg Versus Esomeprazole 40 mg for Healing and Symptomatic Relief of Mild to Moderate Erosive Gastroesophageal Reflux Disease (GERD)
Status: Enrolling
Updated:  1/11/2016
mi
from
Dallas, TX
Rabeprazole Extended-Release 50 mg Versus Esomeprazole 40 mg for Healing and Symptomatic Relief of Mild to Moderate Erosive Gastroesophageal Reflux Disease (GERD)
A Randomized Double-Blind Parallel Study of Rabeprazole Extended-Release 50 mg Versus Esomeprazole 40 mg for Healing and Symptomatic Relief of Mild to Moderate Erosive Gastroesophageal Reflux Disease (GERD)
Status: Enrolling
Updated: 1/11/2016
Clinical Research Facility
mi
from
Dallas, TX
Click here to add this to my saved trials
Rabeprazole Extended-Release 50 mg Versus Esomeprazole 40 mg for Healing and Symptomatic Relief of Mild to Moderate Erosive Gastroesophageal Reflux Disease (GERD)
A Randomized Double-Blind Parallel Study of Rabeprazole Extended-Release 50 mg Versus Esomeprazole 40 mg for Healing and Symptomatic Relief of Mild to Moderate Erosive Gastroesophageal Reflux Disease (GERD)
Status: Enrolling
Updated:  1/11/2016
mi
from
Fort Worth, TX
Rabeprazole Extended-Release 50 mg Versus Esomeprazole 40 mg for Healing and Symptomatic Relief of Mild to Moderate Erosive Gastroesophageal Reflux Disease (GERD)
A Randomized Double-Blind Parallel Study of Rabeprazole Extended-Release 50 mg Versus Esomeprazole 40 mg for Healing and Symptomatic Relief of Mild to Moderate Erosive Gastroesophageal Reflux Disease (GERD)
Status: Enrolling
Updated: 1/11/2016
Clinical Research Facility
mi
from
Fort Worth, TX
Click here to add this to my saved trials
Rabeprazole Extended-Release 50 mg Versus Esomeprazole 40 mg for Healing and Symptomatic Relief of Mild to Moderate Erosive Gastroesophageal Reflux Disease (GERD)
A Randomized Double-Blind Parallel Study of Rabeprazole Extended-Release 50 mg Versus Esomeprazole 40 mg for Healing and Symptomatic Relief of Mild to Moderate Erosive Gastroesophageal Reflux Disease (GERD)
Status: Enrolling
Updated:  1/11/2016
mi
from
Houston, TX
Rabeprazole Extended-Release 50 mg Versus Esomeprazole 40 mg for Healing and Symptomatic Relief of Mild to Moderate Erosive Gastroesophageal Reflux Disease (GERD)
A Randomized Double-Blind Parallel Study of Rabeprazole Extended-Release 50 mg Versus Esomeprazole 40 mg for Healing and Symptomatic Relief of Mild to Moderate Erosive Gastroesophageal Reflux Disease (GERD)
Status: Enrolling
Updated: 1/11/2016
Clinical Research Facility
mi
from
Houston, TX
Click here to add this to my saved trials
Rabeprazole Extended-Release 50 mg Versus Esomeprazole 40 mg for Healing and Symptomatic Relief of Mild to Moderate Erosive Gastroesophageal Reflux Disease (GERD)
A Randomized Double-Blind Parallel Study of Rabeprazole Extended-Release 50 mg Versus Esomeprazole 40 mg for Healing and Symptomatic Relief of Mild to Moderate Erosive Gastroesophageal Reflux Disease (GERD)
Status: Enrolling
Updated:  1/11/2016
mi
from
San Antonio, TX
Rabeprazole Extended-Release 50 mg Versus Esomeprazole 40 mg for Healing and Symptomatic Relief of Mild to Moderate Erosive Gastroesophageal Reflux Disease (GERD)
A Randomized Double-Blind Parallel Study of Rabeprazole Extended-Release 50 mg Versus Esomeprazole 40 mg for Healing and Symptomatic Relief of Mild to Moderate Erosive Gastroesophageal Reflux Disease (GERD)
Status: Enrolling
Updated: 1/11/2016
Clinical Research Facility
mi
from
San Antonio, TX
Click here to add this to my saved trials
Rabeprazole Extended-Release 50 mg Versus Esomeprazole 40 mg for Healing and Symptomatic Relief of Mild to Moderate Erosive Gastroesophageal Reflux Disease (GERD)
A Randomized Double-Blind Parallel Study of Rabeprazole Extended-Release 50 mg Versus Esomeprazole 40 mg for Healing and Symptomatic Relief of Mild to Moderate Erosive Gastroesophageal Reflux Disease (GERD)
Status: Enrolling
Updated:  1/11/2016
mi
from
Chesapeake, VA
Rabeprazole Extended-Release 50 mg Versus Esomeprazole 40 mg for Healing and Symptomatic Relief of Mild to Moderate Erosive Gastroesophageal Reflux Disease (GERD)
A Randomized Double-Blind Parallel Study of Rabeprazole Extended-Release 50 mg Versus Esomeprazole 40 mg for Healing and Symptomatic Relief of Mild to Moderate Erosive Gastroesophageal Reflux Disease (GERD)
Status: Enrolling
Updated: 1/11/2016
Clinical Research Facility
mi
from
Chesapeake, VA
Click here to add this to my saved trials
Rabeprazole Extended-Release 50 mg Versus Esomeprazole 40 mg for Healing and Symptomatic Relief of Mild to Moderate Erosive Gastroesophageal Reflux Disease (GERD)
A Randomized Double-Blind Parallel Study of Rabeprazole Extended-Release 50 mg Versus Esomeprazole 40 mg for Healing and Symptomatic Relief of Mild to Moderate Erosive Gastroesophageal Reflux Disease (GERD)
Status: Enrolling
Updated:  1/11/2016
mi
from
Bellevue, WA
Rabeprazole Extended-Release 50 mg Versus Esomeprazole 40 mg for Healing and Symptomatic Relief of Mild to Moderate Erosive Gastroesophageal Reflux Disease (GERD)
A Randomized Double-Blind Parallel Study of Rabeprazole Extended-Release 50 mg Versus Esomeprazole 40 mg for Healing and Symptomatic Relief of Mild to Moderate Erosive Gastroesophageal Reflux Disease (GERD)
Status: Enrolling
Updated: 1/11/2016
Clinical Research Facility
mi
from
Bellevue, WA
Click here to add this to my saved trials
Rabeprazole Extended-Release 50 mg Versus Esomeprazole 40 mg for Healing and Symptomatic Relief of Mild to Moderate Erosive Gastroesophageal Reflux Disease (GERD)
A Randomized Double-Blind Parallel Study of Rabeprazole Extended-Release 50 mg Versus Esomeprazole 40 mg for Healing and Symptomatic Relief of Mild to Moderate Erosive Gastroesophageal Reflux Disease (GERD)
Status: Enrolling
Updated:  1/11/2016
mi
from
Spokane, WA
Rabeprazole Extended-Release 50 mg Versus Esomeprazole 40 mg for Healing and Symptomatic Relief of Mild to Moderate Erosive Gastroesophageal Reflux Disease (GERD)
A Randomized Double-Blind Parallel Study of Rabeprazole Extended-Release 50 mg Versus Esomeprazole 40 mg for Healing and Symptomatic Relief of Mild to Moderate Erosive Gastroesophageal Reflux Disease (GERD)
Status: Enrolling
Updated: 1/11/2016
Clinical Research Facility
mi
from
Spokane, WA
Click here to add this to my saved trials
Rabeprazole Extended-Release 50 mg Versus Esomeprazole 40 mg for Healing and Symptomatic Relief of Mild to Moderate Erosive Gastroesophageal Reflux Disease (GERD)
A Randomized Double-Blind Parallel Study of Rabeprazole Extended-Release 50 mg Versus Esomeprazole 40 mg for Healing and Symptomatic Relief of Mild to Moderate Erosive Gastroesophageal Reflux Disease (GERD)
Status: Enrolling
Updated:  1/11/2016
mi
from
Madison, WI
Rabeprazole Extended-Release 50 mg Versus Esomeprazole 40 mg for Healing and Symptomatic Relief of Mild to Moderate Erosive Gastroesophageal Reflux Disease (GERD)
A Randomized Double-Blind Parallel Study of Rabeprazole Extended-Release 50 mg Versus Esomeprazole 40 mg for Healing and Symptomatic Relief of Mild to Moderate Erosive Gastroesophageal Reflux Disease (GERD)
Status: Enrolling
Updated: 1/11/2016
Clinical Research Facility
mi
from
Madison, WI
Click here to add this to my saved trials
Rabeprazole Extended-Release 50 mg Versus Esomeprazole 40 mg for Healing and Symptomatic Relief of Mild to Moderate Erosive Gastroesophageal Reflux Disease (GERD)
A Randomized Double-Blind Parallel Study of Rabeprazole Extended-Release 50 mg Versus Esomeprazole 40 mg for Healing and Symptomatic Relief of Mild to Moderate Erosive Gastroesophageal Reflux Disease (GERD)
Status: Enrolling
Updated:  1/11/2016
mi
from
Milwaukee, WI
Rabeprazole Extended-Release 50 mg Versus Esomeprazole 40 mg for Healing and Symptomatic Relief of Mild to Moderate Erosive Gastroesophageal Reflux Disease (GERD)
A Randomized Double-Blind Parallel Study of Rabeprazole Extended-Release 50 mg Versus Esomeprazole 40 mg for Healing and Symptomatic Relief of Mild to Moderate Erosive Gastroesophageal Reflux Disease (GERD)
Status: Enrolling
Updated: 1/11/2016
Clinical Research Facility
mi
from
Milwaukee, WI
Click here to add this to my saved trials
Rabeprazole Extended Release 50 mg Versus Ranitidine 150 mg for Maintenance of Healed Erosive Gastroesophageal Reflux Disease (GERD)
A Randomized Double-Blind Parallel Study of Rabeprazole Extended Release 50 mg Versus Ranitidine 150 mg for Maintenance of Healed Erosive Gastroesophageal Reflux Disease (GERD)
Status: Enrolling
Updated:  1/11/2016
mi
from
Moline, IL
Rabeprazole Extended Release 50 mg Versus Ranitidine 150 mg for Maintenance of Healed Erosive Gastroesophageal Reflux Disease (GERD)
A Randomized Double-Blind Parallel Study of Rabeprazole Extended Release 50 mg Versus Ranitidine 150 mg for Maintenance of Healed Erosive Gastroesophageal Reflux Disease (GERD)
Status: Enrolling
Updated: 1/11/2016
Associates, Ltd.
mi
from
Moline, IL
Click here to add this to my saved trials
Rabeprazole Extended Release 50 mg Versus Ranitidine 150 mg for Maintenance of Healed Erosive Gastroesophageal Reflux Disease (GERD)
A Randomized Double-Blind Parallel Study of Rabeprazole Extended Release 50 mg Versus Ranitidine 150 mg for Maintenance of Healed Erosive Gastroesophageal Reflux Disease (GERD)
Status: Enrolling
Updated:  1/11/2016
mi
from
Moline, IL
Rabeprazole Extended Release 50 mg Versus Ranitidine 150 mg for Maintenance of Healed Erosive Gastroesophageal Reflux Disease (GERD)
A Randomized Double-Blind Parallel Study of Rabeprazole Extended Release 50 mg Versus Ranitidine 150 mg for Maintenance of Healed Erosive Gastroesophageal Reflux Disease (GERD)
Status: Enrolling
Updated: 1/11/2016
Midwest Clinical
mi
from
Moline, IL
Click here to add this to my saved trials
Rabeprazole Extended Release 50 mg Versus Ranitidine 150 mg for Maintenance of Healed Erosive Gastroesophageal Reflux Disease (GERD)
A Randomized Double-Blind Parallel Study of Rabeprazole Extended Release 50 mg Versus Ranitidine 150 mg for Maintenance of Healed Erosive Gastroesophageal Reflux Disease (GERD)
Status: Enrolling
Updated:  1/11/2016
mi
from
Moline, IL
Rabeprazole Extended Release 50 mg Versus Ranitidine 150 mg for Maintenance of Healed Erosive Gastroesophageal Reflux Disease (GERD)
A Randomized Double-Blind Parallel Study of Rabeprazole Extended Release 50 mg Versus Ranitidine 150 mg for Maintenance of Healed Erosive Gastroesophageal Reflux Disease (GERD)
Status: Enrolling
Updated: 1/11/2016
Research
mi
from
Moline, IL
Click here to add this to my saved trials
Rabeprazole Extended Release 50 mg Versus Ranitidine 150 mg for Maintenance of Healed Erosive Gastroesophageal Reflux Disease (GERD)
A Randomized Double-Blind Parallel Study of Rabeprazole Extended Release 50 mg Versus Ranitidine 150 mg for Maintenance of Healed Erosive Gastroesophageal Reflux Disease (GERD)
Status: Enrolling
Updated:  1/11/2016
mi
from
Moline, IL
Rabeprazole Extended Release 50 mg Versus Ranitidine 150 mg for Maintenance of Healed Erosive Gastroesophageal Reflux Disease (GERD)
A Randomized Double-Blind Parallel Study of Rabeprazole Extended Release 50 mg Versus Ranitidine 150 mg for Maintenance of Healed Erosive Gastroesophageal Reflux Disease (GERD)
Status: Enrolling
Updated: 1/11/2016
Clinical Research Facility
mi
from
Moline, IL
Click here to add this to my saved trials
The Role Of Gastroesophageal Reflux Disease (GERD) in Eosinophilic Esophagitis
The Role Of Gastroesophageal Reflux Disease (GERD) in Eosinophilic Esophagitis
Status: Enrolling
Updated:  1/12/2016
mi
from
Rochester, MN
The Role Of Gastroesophageal Reflux Disease (GERD) in Eosinophilic Esophagitis
The Role Of Gastroesophageal Reflux Disease (GERD) in Eosinophilic Esophagitis
Status: Enrolling
Updated: 1/12/2016
The Mayo Clinic
mi
from
Rochester, MN
Click here to add this to my saved trials
Multi Modal Imaging: An MRI Study to Investigate Differences in the Structure and the Function of the Brain at Rest.
A Magnetic Resonance Imaging (MRI) Study to Investigate Differences in the Structure and the Function of the Brain at Rest; Between Persons With Functional Pain Conditions Such as IBS or Vulvodynia, IBD and Healthy Controls
Status: Enrolling
Updated:  1/12/2016
mi
from
Los Angeles, CA
Multi Modal Imaging: An MRI Study to Investigate Differences in the Structure and the Function of the Brain at Rest.
A Magnetic Resonance Imaging (MRI) Study to Investigate Differences in the Structure and the Function of the Brain at Rest; Between Persons With Functional Pain Conditions Such as IBS or Vulvodynia, IBD and Healthy Controls
Status: Enrolling
Updated: 1/12/2016
Gail and Gerald Oppenheimer Family Center for Neurobiology of Stress
mi
from
Los Angeles, CA
Click here to add this to my saved trials
Development and Validation of the Automated Evaluation of Gastrointestinal Symptoms (AEGIS) Platform
Development and Validation of the Automated Evaluation of Gastrointestinal Symptoms (AEGIS) Platform
Status: Enrolling
Updated:  1/13/2016
mi
from
Los Angeles, CA
Development and Validation of the Automated Evaluation of Gastrointestinal Symptoms (AEGIS) Platform
Development and Validation of the Automated Evaluation of Gastrointestinal Symptoms (AEGIS) Platform
Status: Enrolling
Updated: 1/13/2016
Cedars-Sinai Medical Center
mi
from
Los Angeles, CA
Click here to add this to my saved trials
Development and Validation of the Automated Evaluation of Gastrointestinal Symptoms (AEGIS) Platform
Development and Validation of the Automated Evaluation of Gastrointestinal Symptoms (AEGIS) Platform
Status: Enrolling
Updated:  1/13/2016
mi
from
Los Angeles, CA
Development and Validation of the Automated Evaluation of Gastrointestinal Symptoms (AEGIS) Platform
Development and Validation of the Automated Evaluation of Gastrointestinal Symptoms (AEGIS) Platform
Status: Enrolling
Updated: 1/13/2016
West Los Angeles VA Medical Center
mi
from
Los Angeles, CA
Click here to add this to my saved trials
Development and Validation of the Automated Evaluation of Gastrointestinal Symptoms (AEGIS) Platform
Development and Validation of the Automated Evaluation of Gastrointestinal Symptoms (AEGIS) Platform
Status: Enrolling
Updated:  1/13/2016
mi
from
Ann Arbor, MI
Development and Validation of the Automated Evaluation of Gastrointestinal Symptoms (AEGIS) Platform
Development and Validation of the Automated Evaluation of Gastrointestinal Symptoms (AEGIS) Platform
Status: Enrolling
Updated: 1/13/2016
University of Michigan
mi
from
Ann Arbor, MI
Click here to add this to my saved trials
Biology in Patients With Reflux Esophagitis
Biology in Patients With Reflux Esophagitis and Mucosal Impedance
Status: Enrolling
Updated:  1/19/2016
mi
from
Nashville, TN
Biology in Patients With Reflux Esophagitis
Biology in Patients With Reflux Esophagitis and Mucosal Impedance
Status: Enrolling
Updated: 1/19/2016
Vanderbilt University Digestive Diseases Center
mi
from
Nashville, TN
Click here to add this to my saved trials
Effect of Acid Reflux on Respiratory Physiology During Exercise in Athletes With GER-Response to Acid Suppression
Effect of Acid Reflux on Respiratory Physiology During Exercise in Athletes With GER-Response to Acid Suppression
Status: Enrolling
Updated:  1/19/2016
mi
from
Salt Lake City, UT
Effect of Acid Reflux on Respiratory Physiology During Exercise in Athletes With GER-Response to Acid Suppression
Effect of Acid Reflux on Respiratory Physiology During Exercise in Athletes With GER-Response to Acid Suppression
Status: Enrolling
Updated: 1/19/2016
University of Utah Health Sciences Center
mi
from
Salt Lake City, UT
Click here to add this to my saved trials
Can We Predict Who Has Gastroesophageal Reflux Disease (GERD)?
Can We Predict Who Has GERD? Systematic Evaluation of Role of pH Monitoring and the Specific Physiologic pH Parameters in Defining GERD, Bravo, Impedence and SISAP
Status: Enrolling
Updated:  1/19/2016
mi
from
Nashville, TN
Can We Predict Who Has Gastroesophageal Reflux Disease (GERD)?
Can We Predict Who Has GERD? Systematic Evaluation of Role of pH Monitoring and the Specific Physiologic pH Parameters in Defining GERD, Bravo, Impedence and SISAP
Status: Enrolling
Updated: 1/19/2016
Vanderbilt University Medical Center GI Outpatient Clinic
mi
from
Nashville, TN
Click here to add this to my saved trials
Assessment of Esophageal Epithelium Integrity With Mucosal Impedance
Assessment of Esophageal Epithelium Integrity With Mucosal Impedance
Status: Enrolling
Updated:  1/19/2016
mi
from
Nashville, TN
Assessment of Esophageal Epithelium Integrity With Mucosal Impedance
Assessment of Esophageal Epithelium Integrity With Mucosal Impedance
Status: Enrolling
Updated: 1/19/2016
Vanderbilt University Medical Center
mi
from
Nashville, TN
Click here to add this to my saved trials
Long-term Outcome of Laparoscopic Hiatal Hernia Repair With or Without Alloderm Mesh at a University Hospital
Long-term Outcome of Laparoscopic Hiatal Hernia Repair With or Without Alloderm Mesh at a University Hospital
Status: Enrolling
Updated:  5/10/2016
mi
from
Omaha, NE
Long-term Outcome of Laparoscopic Hiatal Hernia Repair With or Without Alloderm Mesh at a University Hospital
Long-term Outcome of Laparoscopic Hiatal Hernia Repair With or Without Alloderm Mesh at a University Hospital
Status: Enrolling
Updated: 5/10/2016
Univ of Nebraska Med Ctr
mi
from
Omaha, NE
Click here to add this to my saved trials
Morphological Markers of Gastroesophageal Reflux Disease (GERD)
Dilation of Intercellular Spaces as Morphological Markers of Gastroesophageal Reflux Disease (GERD)In Children
Status: Enrolling
Updated:  6/29/2016
mi
from
Houston, TX
Morphological Markers of Gastroesophageal Reflux Disease (GERD)
Dilation of Intercellular Spaces as Morphological Markers of Gastroesophageal Reflux Disease (GERD)In Children
Status: Enrolling
Updated: 6/29/2016
Texas Children's Hospital
mi
from
Houston, TX
Click here to add this to my saved trials
Image-Enhanced Endoscopy (IEE) for Diagnosis of Non-Erosive Reflux Disease
Image-Enhanced Endoscopy for the Diagnosis of Non-Erosive Reflux Disease: A Prospective Case-Control Trial
Status: Enrolling
Updated:  7/11/2016
mi
from
New Haven, CT
Image-Enhanced Endoscopy (IEE) for Diagnosis of Non-Erosive Reflux Disease
Image-Enhanced Endoscopy for the Diagnosis of Non-Erosive Reflux Disease: A Prospective Case-Control Trial
Status: Enrolling
Updated: 7/11/2016
Yale-New Haven Hospital
mi
from
New Haven, CT
Click here to add this to my saved trials
Image-Enhanced Endoscopy (IEE) for Diagnosis of Non-Erosive Reflux Disease
Image-Enhanced Endoscopy for the Diagnosis of Non-Erosive Reflux Disease: A Prospective Case-Control Trial
Status: Enrolling
Updated:  7/11/2016
mi
from
West Haven, CT
Image-Enhanced Endoscopy (IEE) for Diagnosis of Non-Erosive Reflux Disease
Image-Enhanced Endoscopy for the Diagnosis of Non-Erosive Reflux Disease: A Prospective Case-Control Trial
Status: Enrolling
Updated: 7/11/2016
VACHS
mi
from
West Haven, CT
Click here to add this to my saved trials
Integrating Targeted MedlinePlus Health Prescriptions Into Clinic Practice Workflow
Integrating Targeted MedlinePlus Health Prescriptions Into Clinic Practice Workflow
Status: Enrolling
Updated:  8/15/2016
mi
from
Columbia, MO
Integrating Targeted MedlinePlus Health Prescriptions Into Clinic Practice Workflow
Integrating Targeted MedlinePlus Health Prescriptions Into Clinic Practice Workflow
Status: Enrolling
Updated: 8/15/2016
University of Missouri, Department of Internal Medicine
mi
from
Columbia, MO
Click here to add this to my saved trials
Can Quercetin Increase Claudin-4 and Improve Esophageal Barrier Function in GERD?
Can Quercetin Increase Claudin-4 and Improve Esophageal Barrier Function in GERD?
Status: Enrolling
Updated:  12/19/2016
mi
from
CHapel Hill, NC
Can Quercetin Increase Claudin-4 and Improve Esophageal Barrier Function in GERD?
Can Quercetin Increase Claudin-4 and Improve Esophageal Barrier Function in GERD?
Status: Enrolling
Updated: 12/19/2016
UNC Chapel Hill
mi
from
CHapel Hill, NC
Click here to add this to my saved trials
Prospective Randomized Trial Evaluating the Utility of Esophageal Stitches During Laparoscopic Fundoplication
Prospective Randomized Trial Evaluating the Utility of Esophageal Stitches During Laparoscopic Fundoplication.
Status: Enrolling
Updated:  1/25/2017
mi
from
Kansas City, MO
Prospective Randomized Trial Evaluating the Utility of Esophageal Stitches During Laparoscopic Fundoplication
Prospective Randomized Trial Evaluating the Utility of Esophageal Stitches During Laparoscopic Fundoplication.
Status: Enrolling
Updated: 1/25/2017
Children's Mercy Hospital
mi
from
Kansas City, MO
Click here to add this to my saved trials
Cough Reflex Sensitivity and Bronchial Hyper-responsiveness
Pilot Studies Evaluating Cough Reflex Sensitivity and Bronchial Hyper-responsiveness: The Road to Cough and Wheeze in Patients With Gastroesophageal Reflux.
Status: Enrolling
Updated:  2/16/2017
mi
from
Jacksonville, FL
Cough Reflex Sensitivity and Bronchial Hyper-responsiveness
Pilot Studies Evaluating Cough Reflex Sensitivity and Bronchial Hyper-responsiveness: The Road to Cough and Wheeze in Patients With Gastroesophageal Reflux.
Status: Enrolling
Updated: 2/16/2017
Mayo Clinic Florida
mi
from
Jacksonville, FL
Click here to add this to my saved trials
Proton Pump Inhibitor (PPI) Responsive Eosinophilic Esophagitis EoE: Gastroesophageal Reflux Disease (GERD) or Eosinophilic Esophagitis (EoE)?
PPI Responsive Esophageal Eosinophilia: GERD or Eosinophilic Esophagitis?
Status: Enrolling
Updated:  3/21/2017
mi
from
Rochester, MN
Proton Pump Inhibitor (PPI) Responsive Eosinophilic Esophagitis EoE: Gastroesophageal Reflux Disease (GERD) or Eosinophilic Esophagitis (EoE)?
PPI Responsive Esophageal Eosinophilia: GERD or Eosinophilic Esophagitis?
Status: Enrolling
Updated: 3/21/2017
The Mayo Clinic
mi
from
Rochester, MN
Click here to add this to my saved trials
Clinical Applications of Domperidone in Patients With Delayed Gastric Emptying
Clinical Applications of Domperidone in Patients With Refractory Gastroesophageal Reflux Disease or Delayed Gastric Solid-Phase Emptying
Status: Enrolling
Updated:  5/15/2017
mi
from
Miami Beach, FL
Clinical Applications of Domperidone in Patients With Delayed Gastric Emptying
Clinical Applications of Domperidone in Patients With Refractory Gastroesophageal Reflux Disease or Delayed Gastric Solid-Phase Emptying
Status: Enrolling
Updated: 5/15/2017
Division of Gastroenterology, Mt. Sinai Medical Center
mi
from
Miami Beach, FL
Click here to add this to my saved trials
Clinical Applications of Domperidone in Patients With Delayed Gastric Emptying
Clinical Applications of Domperidone in Patients With Refractory Gastroesophageal Reflux Disease or Delayed Gastric Solid-Phase Emptying
Status: Enrolling
Updated:  5/15/2017
mi
from
Miami Beach, FL
Clinical Applications of Domperidone in Patients With Delayed Gastric Emptying
Clinical Applications of Domperidone in Patients With Refractory Gastroesophageal Reflux Disease or Delayed Gastric Solid-Phase Emptying
Status: Enrolling
Updated: 5/15/2017
Mt. Sinai Medical Center, Division of Gastroenterology
mi
from
Miami Beach, FL
Click here to add this to my saved trials
Clinical Applications of Domperidone in Patients With Delayed Gastric Emptying
Clinical Applications of Domperidone in Patients With Refractory Gastroesophageal Reflux Disease or Delayed Gastric Solid-Phase Emptying
Status: Enrolling
Updated:  5/15/2017
mi
from
Miami Beach, FL
Clinical Applications of Domperidone in Patients With Delayed Gastric Emptying
Clinical Applications of Domperidone in Patients With Refractory Gastroesophageal Reflux Disease or Delayed Gastric Solid-Phase Emptying
Status: Enrolling
Updated: 5/15/2017
Mt. Sinai Medical Center, Division of Gastroenterology
mi
from
Miami Beach, FL
Click here to add this to my saved trials
Effect of PEM Treatment of Superficial Axial and Tributary Vein Reflux on Improvement of Wound Healing in VLUs
Effect of Polidocanol Endovenous Microfoam (PEM) Treatment of Superficial Axial and Tributary Vein Reflux on Improvement of Wound Healing in Venous Leg Ulcers (VLUs)
Status: Enrolling
Updated:  9/14/2017
mi
from
Columbus, OH
Effect of PEM Treatment of Superficial Axial and Tributary Vein Reflux on Improvement of Wound Healing in VLUs
Effect of Polidocanol Endovenous Microfoam (PEM) Treatment of Superficial Axial and Tributary Vein Reflux on Improvement of Wound Healing in Venous Leg Ulcers (VLUs)
Status: Enrolling
Updated: 9/14/2017
OhioHealth Riverside Methodist Hospital
mi
from
Columbus, OH
Click here to add this to my saved trials
A Randomized, Double-blind, Placebo-controlled,Trial of IW-3718 for 8 Weeks in Patient With Symptomatic GERD
A Phase 2b, Randomized, Double-blind, Placebo-controlled, Parallel-group, Dose-range-finding Trial of IW-3718 Administered Orally for 8 Weeks to Patients With Symptomatic GERD That Persists Despite Treatment With Proton Pump Inhibitors
Status: Enrolling
Updated:  9/25/2017
mi
from
Birmingham, AL
A Randomized, Double-blind, Placebo-controlled,Trial of IW-3718 for 8 Weeks in Patient With Symptomatic GERD
A Phase 2b, Randomized, Double-blind, Placebo-controlled, Parallel-group, Dose-range-finding Trial of IW-3718 Administered Orally for 8 Weeks to Patients With Symptomatic GERD That Persists Despite Treatment With Proton Pump Inhibitors
Status: Enrolling
Updated: 9/25/2017
IW-3718 Investigator
mi
from
Birmingham, AL
Click here to add this to my saved trials
A Randomized, Double-blind, Placebo-controlled,Trial of IW-3718 for 8 Weeks in Patient With Symptomatic GERD
A Phase 2b, Randomized, Double-blind, Placebo-controlled, Parallel-group, Dose-range-finding Trial of IW-3718 Administered Orally for 8 Weeks to Patients With Symptomatic GERD That Persists Despite Treatment With Proton Pump Inhibitors
Status: Enrolling
Updated:  9/25/2017
mi
from
Dothan, AL
A Randomized, Double-blind, Placebo-controlled,Trial of IW-3718 for 8 Weeks in Patient With Symptomatic GERD
A Phase 2b, Randomized, Double-blind, Placebo-controlled, Parallel-group, Dose-range-finding Trial of IW-3718 Administered Orally for 8 Weeks to Patients With Symptomatic GERD That Persists Despite Treatment With Proton Pump Inhibitors
Status: Enrolling
Updated: 9/25/2017
(410) 601-8256
mi
from
Dothan, AL
Click here to add this to my saved trials
A Randomized, Double-blind, Placebo-controlled,Trial of IW-3718 for 8 Weeks in Patient With Symptomatic GERD
A Phase 2b, Randomized, Double-blind, Placebo-controlled, Parallel-group, Dose-range-finding Trial of IW-3718 Administered Orally for 8 Weeks to Patients With Symptomatic GERD That Persists Despite Treatment With Proton Pump Inhibitors
Status: Enrolling
Updated:  9/25/2017
mi
from
Tucson, AZ
A Randomized, Double-blind, Placebo-controlled,Trial of IW-3718 for 8 Weeks in Patient With Symptomatic GERD
A Phase 2b, Randomized, Double-blind, Placebo-controlled, Parallel-group, Dose-range-finding Trial of IW-3718 Administered Orally for 8 Weeks to Patients With Symptomatic GERD That Persists Despite Treatment With Proton Pump Inhibitors
Status: Enrolling
Updated: 9/25/2017
IW-3718 Investigator
mi
from
Tucson, AZ
Click here to add this to my saved trials
A Randomized, Double-blind, Placebo-controlled,Trial of IW-3718 for 8 Weeks in Patient With Symptomatic GERD
A Phase 2b, Randomized, Double-blind, Placebo-controlled, Parallel-group, Dose-range-finding Trial of IW-3718 Administered Orally for 8 Weeks to Patients With Symptomatic GERD That Persists Despite Treatment With Proton Pump Inhibitors
Status: Enrolling
Updated:  9/25/2017
mi
from
North Little Rock, AR
A Randomized, Double-blind, Placebo-controlled,Trial of IW-3718 for 8 Weeks in Patient With Symptomatic GERD
A Phase 2b, Randomized, Double-blind, Placebo-controlled, Parallel-group, Dose-range-finding Trial of IW-3718 Administered Orally for 8 Weeks to Patients With Symptomatic GERD That Persists Despite Treatment With Proton Pump Inhibitors
Status: Enrolling
Updated: 9/25/2017
IW-3718 Investigator
mi
from
North Little Rock, AR
Click here to add this to my saved trials
A Randomized, Double-blind, Placebo-controlled,Trial of IW-3718 for 8 Weeks in Patient With Symptomatic GERD
A Phase 2b, Randomized, Double-blind, Placebo-controlled, Parallel-group, Dose-range-finding Trial of IW-3718 Administered Orally for 8 Weeks to Patients With Symptomatic GERD That Persists Despite Treatment With Proton Pump Inhibitors
Status: Enrolling
Updated:  9/25/2017
mi
from
Anaheim, CA
A Randomized, Double-blind, Placebo-controlled,Trial of IW-3718 for 8 Weeks in Patient With Symptomatic GERD
A Phase 2b, Randomized, Double-blind, Placebo-controlled, Parallel-group, Dose-range-finding Trial of IW-3718 Administered Orally for 8 Weeks to Patients With Symptomatic GERD That Persists Despite Treatment With Proton Pump Inhibitors
Status: Enrolling
Updated: 9/25/2017
IW-3718 Investigator
mi
from
Anaheim, CA
Click here to add this to my saved trials
A Randomized, Double-blind, Placebo-controlled,Trial of IW-3718 for 8 Weeks in Patient With Symptomatic GERD
A Phase 2b, Randomized, Double-blind, Placebo-controlled, Parallel-group, Dose-range-finding Trial of IW-3718 Administered Orally for 8 Weeks to Patients With Symptomatic GERD That Persists Despite Treatment With Proton Pump Inhibitors
Status: Enrolling
Updated:  9/25/2017
mi
from
Carmichael, CA
A Randomized, Double-blind, Placebo-controlled,Trial of IW-3718 for 8 Weeks in Patient With Symptomatic GERD
A Phase 2b, Randomized, Double-blind, Placebo-controlled, Parallel-group, Dose-range-finding Trial of IW-3718 Administered Orally for 8 Weeks to Patients With Symptomatic GERD That Persists Despite Treatment With Proton Pump Inhibitors
Status: Enrolling
Updated: 9/25/2017
IW-3718 Investigator
mi
from
Carmichael, CA
Click here to add this to my saved trials
A Randomized, Double-blind, Placebo-controlled,Trial of IW-3718 for 8 Weeks in Patient With Symptomatic GERD
A Phase 2b, Randomized, Double-blind, Placebo-controlled, Parallel-group, Dose-range-finding Trial of IW-3718 Administered Orally for 8 Weeks to Patients With Symptomatic GERD That Persists Despite Treatment With Proton Pump Inhibitors
Status: Enrolling
Updated:  9/25/2017
mi
from
Chula Vista, CA
A Randomized, Double-blind, Placebo-controlled,Trial of IW-3718 for 8 Weeks in Patient With Symptomatic GERD
A Phase 2b, Randomized, Double-blind, Placebo-controlled, Parallel-group, Dose-range-finding Trial of IW-3718 Administered Orally for 8 Weeks to Patients With Symptomatic GERD That Persists Despite Treatment With Proton Pump Inhibitors
Status: Enrolling
Updated: 9/25/2017
IW-3718 Investigator
mi
from
Chula Vista, CA
Click here to add this to my saved trials